Boardroom Alpha
Boardroom Alpha
CLB · Additional Proxy Materials (DEFA14A) · Filed March 31, 2026

Core Laboratories Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
March 31, 2026
Ticker
CLB
Accession
0001193125-26-134991
Boardroom Alpha · Filing insights

Core Laboratories seeks to re-elect Class I directors and ratify auditors for 2026. It seeks advisory approval of executive compensation.

About Core Laboratories Inc
Market cap
$627M
1Y TSR
+17.9%
3Y TSR
−16.3%
Board grade
C-
Sector
Energy
CEO
Lawrence Bruno
Last annual meeting: May 12, 2026 · View full Core Laboratories Inc profile →
DEFA14A

 

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934 (Amendment No. )

 

Filed by the Registrant ☑

Filed by a Party other than the Registrant ☐

 

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

☑ Definitive Additional Materials

☐ Soliciting Material Pursuant to §240.14a-12

 

Core Laboratories Inc.

 

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☑ No fee required

☐ Fee paid previously with preliminary materials

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

1


 

*** Exercise Your Right to Vote ***

IMPORTANT NOTICE Regarding the Availability of Proxy Materials

for the Shareholder Meeting To Be Held on May 12, 2026

 

 

 

 

 

Meeting Information

CORE LABORATORIES INC.

 

Meeting Type:

Annual Meeting

 

 

For holders as of:

March 18, 2026

 

 

Date: May 12, 2026

Time: 9:00 am CDT

 

 

Location:

The Hotel Zaza, Memorial City

 

 

 

9787 Katy Freeway

 

 

 

Houston, Texas 77024

img30012974_0.jpg

CORE LABORATORIES INC.

 

You are receiving this communication because you hold shares in the above named company.

6316 WINDFERN ROAD

HOUSTON, TX 77040

 

This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

 

 

 

 

The proxy materials are available at www.proxyvote.com. If you want to receive a paper or e-mail copy of these documents, you must request one. There is no charge to you for requesting a copy. Please make your request for a copy (as instructed on the reverse side) on or before April 28, 2026 to facilitate timely delivery.

 

 

 

 

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

 

2


 

— Before You Vote —

How to Access the Proxy Materials

 

Proxy Materials Available to VIEW or RECEIVE:

NOTICE AND PROXY STATEMENT

ANNUAL REPORT

 

 

 

 

 

 

 

How to View Online:

 

 

 

 

Have the information that is printed in the box marked by the arrow

XXXX XXXX XXXX

(located on the following page) and

visit: www.proxyvote.com.

 

 

 

 

 

How to Request and Receive a PAPER or E-MAIL Copy:

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 

1) BY INTERNET:

The proxy materials are available at www.proxyvote.com.

 

2) BY TELEPHONE:

1-800-579-1639

 

 

 

3) BY E-MAIL*:

sendmaterial@proxyvote.com

 

 

 

 

 

 

 

* If requesting materials by e-mail, please send a blank e-mail with the information that is printed

in the box marked by the arrow

XXXX XXXX XXXX

 (located on the following page) in the subject line.

 

 

 

 

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before April 28, 2026 to facilitate timely delivery.

 

 

— How To Vote —

Please Choose One of the Following Voting Methods

Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.

 

 

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box

marked by the arrow

XXXX XXXX XXXX

available and follow the instructions.

 

 

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.

 

3


 

 

 

 

The Board of Directors recommends you vote FOR the following:

 

For

Withhold

1.

To re-elect two current Class I Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2029 and until their successors shall have been duly elected and qualified;

 

 

 

 

1a) Harvey Klingensmith

 

 

1b) Curtis Anastasio

The Board of Directors recommends you vote FOR the following proposals:

For

Against

Abstain

 

 

 

 

 

 

 

2.

To ratify the appointment of KPMG LLP as the Company’s independent registered public accountants for the year ending December 31, 2026;

 

3.

To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis (“CD&A”), and the compensation of the Company’s named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commission’s compensation disclosure rules, including the compensation tables.

 

 

 

 

 

 

NOTE: Such other business as may properly come before the annual meeting or any adjournment thereof shall be voted in accordance with the discretion of the attorneys and proxies appointed hereby.

 

 

 

 

4


From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Core Laboratories Inc (CLB)

Reference

Frequently asked questions

When did Core Laboratories Inc file this DEFA14A?
Core Laboratories Inc (CLB) filed this Additional Proxy Materials (DEFA14A) with the SEC on March 31, 2026. The accession number assigned by EDGAR is 0001193125-26-134991.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Core Laboratories seeks to re-elect Class I directors and ratify auditors for 2026. It seeks advisory approval of executive compensation. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Core Laboratories Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Core Laboratories Inc has filed under CIK 1958086, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer